Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

This study is ongoing, but not recruiting participants.

Study NCT00527657 Information provided by M.D. Anderson Cancer Center

First Received: September 10, 2007 Last Updated: September 14, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	February 2013 (Final data collection date for primary outcome measure)